Form D · Biotechnology

Zura Bio Ltd

Henderson, NV · CIK 0001855644

Offering snapshot reported May 6, 2024 · SEC filing

Reported sold
$112M
Offering amount: $113M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 22, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 6, 2024Initial$112,499,985No comparison19SEC filing
May 5, 2023Initial$15,937,500No comparison21SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$6.75M
Form D file number
021-512488
The total offering amount above includes the amount, if any, that the Issuer could receive if all of the issued Warrants were exercised and is reflected in the Total Remaining to be Sold.

Source: Form D, filed May 6, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Verender Badial Executive
Christopher Cabell Executive
Kim Davis Executive
Neil Graham Director
Michael Howell Executive
Jennifer Jarrett Director
Sandeep Kulkarni Director
Robert Lisicki Director, Executive
Amit Munshi Director
Garry Neil Director
Kiran Nistala Executive
Arnout Ploos Van Amstel Director
Steven Schoch Director
Someit Sidhu Director
Parvinder Thiara Director
Gary Whale Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1489 W. Warm Springs Road Suite 110
Henderson, NV, 89014